Impact of the Spread of COVID-19 on the Continuation of Business Activities
First written in FY2020. 4 of 11 entries say "Mitigated", first in FY2023-Q3. Latest entry: FY2024-Q3.
Toyo Gosei moved to the "Worse" side of this theme in 2020, the same year as the typical company in this theme.
The whole theme swung hardest in 2025: 7 of 24 companies on the "Worse" side.
25 other companies' latest entry also says "Mitigated".
- FY2024-Q3MitigatedAnnual report
「In Japan, service demand, including personal consumption and inbound tourism, expanded as a result of COVID-19 being reclassified as a Category 5 infectious disease, and the economy continued its moderate recovery.」
Service demand expanded following the reclassification of COVID-19 as a Category 5 infectious disease, indicating that constraints on economic activity caused by the infection have eased further. - FY2024-Q1MitigatedAnnual report
「In Japan, service demand, including personal consumption and inbound tourism, recovered as a result of COVID-19 being reclassified as a Category 5 infectious disease, among other factors. Corporate capital investment also increased, and the economy entered a moderate recovery trend.」
The reclassification of COVID-19 as a Category 5 infectious disease is described as a factor behind the recovery in personal consumption and other areas, indicating that constraints on economic activity caused by the infection have eased further. - FY2023MitigatedAnnual report
「The semiconductor market has undergone production adjustments due to the buildup of product inventories resulting from supply chain disruptions during the COVID-19 pandemic and a decline in consumption caused by global inflation.」
While the impact of COVID-19 has diminished as economic activity normalizes, the disclosure states that inventory buildup and production adjustments resulting from supply chain disruptions remain. - FY2023-Q3MitigatedAnnual report
「The electronic materials industry saw the impact of COVID-19 diminish, and global logistics disruptions moved toward normalization, with some semiconductor shortages being resolved, but」
The disclosure describes the diminishing impact of COVID-19 and the normalization of logistics disruptions. - FY2022RestatedAnnual report
「During the fiscal year, the Japanese economy continued to be affected by COVID-19, but economic activity resumed as vaccines became more widely available and signs of a recovery emerged.」
While the impact of the infection continued, the disclosure also describes the resumption of economic activity due to the wider availability of vaccines and other factors, indicating that the risk of infection affecting business activities remains recognized. - FY2022-Q3WorsenedAnnual report
「The global economy saw the spread of infection peak temporarily in countries and regions including the United States, Europe and China, and economic activity resumed in earnest. However, it also experienced periods of downturn, including a temporary restraint on consumption due to the renewed spread of the Omicron variant.」
The renewed spread of infection, restraint on consumption caused by the Omicron variant, and a downturn in economic activity are explicitly described, indicating that the risk of the spread of infection affecting business activities and performance has entered a new phase. - FY2022-Q1RestatedAnnual report
「During the first quarter, the Japanese economy continued to be affected by the spread of COVID-19, including the reissuance of a state of emergency.」
The disclosure states that the effects of the spread of the infection and the state of emergency continued, and that the risks to the continuity of production, logistics and sales activities remain recognized. - FY2021MaterialisedAnnual report
「During the fiscal year, the Japanese economy continued to be affected by the spread of COVID-19 throughout the year, including the issuance of a state of emergency.」
The spread of COVID-19 and the state of emergency continued throughout the year, affecting economic activity and demand for logistics, according to the disclosure. - FY2021-Q2MaterialisedAnnual report
「In addition, we have determined that the spread of COVID-19 had only a minor impact on our production, logistics and sales operations and other business activities, as well as on our business performance, during the cumulative second quarter. However, COVID-19 had not subsided as of the date of submission of this quarterly report, and if further spread of the infection disrupts the continuity of our production, logistics and sales operations and other business activities, it could have a material impact on our business performance.」
The spread of COVID-19 continues, but its impact on the Company's business activities and performance during the cumulative second quarter was judged to be minor. Meanwhile, the risk that future spread could disrupt business continuity remains. - FY2021-Q1MaterialisedAnnual report
「In addition, we have determined that the spread of COVID-19 had only a minor impact on our production, logistics and sales operations and other business activities, as well as on our business performance, during the cumulative first quarter. However, COVID-19 had not subsided as of the date of submission of this quarterly report, and if further spread of the infection disrupts the continuity of our production, logistics and sales operations and other business activities, it could have a material impact on our business performance.」
The spread of COVID-19 became a reality, but its impact on the Company during the first quarter was judged to be minor. Meanwhile, the risk that further spread of the infection could disrupt business continuity remains. - FY2020First statedAnnual report
「In addition, if the spread of infectious diseases such as COVID-19 disrupts the continuity of our business activities, including our production, logistics and sales operations, it could have a material impact on our business performance.」
The possibility that the spread of infectious diseases such as COVID-19 could disrupt the continuity of production, logistics and sales activities has been disclosed explicitly as an independent risk for the first time.